These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18076768)

  • 1. Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.
    Sterjovski J; Churchill MJ; Ellett A; Gray LR; Roche MJ; Dunfee RL; Purcell DF; Saksena N; Wang B; Sonza S; Wesselingh SL; Karlsson I; Fenyo EM; Gabuzda D; Cunningham AL; Gorry PR
    Retrovirology; 2007 Dec; 4():89. PubMed ID: 18076768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.
    Wade J; Sterjovski J; Gray L; Roche M; Chiavaroli L; Ellett A; Jakobsen MR; Cowley D; Pereira Cda F; Saksena N; Wang B; Purcell DF; Karlsson I; Fenyö EM; Churchill M; Gorry PR
    Virology; 2010 Jan; 396(2):246-55. PubMed ID: 19913863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity.
    Sterjovski J; Churchill MJ; Roche M; Ellett A; Farrugia W; Wesselingh SL; Cunningham AL; Ramsland PA; Gorry PR
    Virology; 2011 Feb; 410(2):418-28. PubMed ID: 21216423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues.
    Gray L; Sterjovski J; Ramsland PA; Churchill MJ; Gorry PR
    Retrovirology; 2011 Jun; 8():42. PubMed ID: 21635737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.
    Gorry PR; Taylor J; Holm GH; Mehle A; Morgan T; Cayabyab M; Farzan M; Wang H; Bell JE; Kunstman K; Moore JP; Wolinsky SM; Gabuzda D
    J Virol; 2002 Jun; 76(12):6277-92. PubMed ID: 12021361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.
    Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DF; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR
    J Virol; 2009 Jun; 83(11):5430-41. PubMed ID: 19321618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.
    Borggren M; Repits J; Kuylenstierna C; Sterjovski J; Churchill MJ; Purcell DF; Karlsson A; Albert J; Gorry PR; Jansson M
    Retrovirology; 2008 Mar; 5():28. PubMed ID: 18371209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc.
    Borm K; Jakobsen MR; Cashin K; Flynn JK; Ellenberg P; Ostergaard L; Lee B; Churchill MJ; Roche M; Gorry PR
    Retrovirology; 2016 Nov; 13(1):74. PubMed ID: 27809912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
    Parrish NF; Wilen CB; Banks LB; Iyer SS; Pfaff JM; Salazar-Gonzalez JF; Salazar MG; Decker JM; Parrish EH; Berg A; Hopper J; Hora B; Kumar A; Mahlokozera T; Yuan S; Coleman C; Vermeulen M; Ding H; Ochsenbauer C; Tilton JC; Permar SR; Kappes JC; Betts MR; Busch MP; Gao F; Montefiori D; Haynes BF; Shaw GM; Hahn BH; Doms RW
    PLoS Pathog; 2012; 8(5):e1002686. PubMed ID: 22693444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
    Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
    Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5.
    Salimi H; Roche M; Webb N; Gray LR; Chikere K; Sterjovski J; Ellett A; Wesselingh SL; Ramsland PA; Lee B; Churchill MJ; Gorry PR
    J Leukoc Biol; 2013 Jan; 93(1):113-26. PubMed ID: 23077246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
    O'Connell O; Repik A; Reeves JD; Gonzalez-Perez MP; Quitadamo B; Anton ED; Duenas-Decamp M; Peters P; Lin R; Zolla-Pazner S; Corti D; Wallace A; Wang S; Kong XP; Lu S; Clapham PR
    J Virol; 2013 Jan; 87(1):187-98. PubMed ID: 23055568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
    Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
    Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.
    Thomas ER; Dunfee RL; Stanton J; Bogdan D; Taylor J; Kunstman K; Bell JE; Wolinsky SM; Gabuzda D
    Virology; 2007 Mar; 360(1):105-19. PubMed ID: 17084877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity.
    Puffer BA; Pöhlmann S; Edinger AL; Carlin D; Sanchez MD; Reitter J; Watry DD; Fox HS; Desrosiers RC; Doms RW
    J Virol; 2002 Mar; 76(6):2595-605. PubMed ID: 11861825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
    Repits J; Sterjovski J; Badia-Martinez D; Mild M; Gray L; Churchill MJ; Purcell DF; Karlsson A; Albert J; Fenyö EM; Achour A; Gorry PR; Jansson M
    Virology; 2008 Sep; 379(1):125-34. PubMed ID: 18672260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.